{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "COCO",
  "name": "The Vita Coco Company, Inc.",
  "url": "https://orbyd.app/dossiers/COCO/",
  "json_url": "https://orbyd.app/dossiers/COCO.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": null,
  "archetype": {
    "code": "a1",
    "n": 1
  },
  "current_thesis": "Q2 FY26 (2026-07-23) beat on every line — net sales $216.2M +28.1%, EPS $0.82 vs ~$0.55, FY guide raised to $790–805M — and the stock still closed $62.25 on 2026-08-07, -25.9% from the post-print high. Beat-and-raise absorbed by sellers; no dated catalyst until an unannounced Q3 print, and the ~$60 April gap shelf is the last structure standing.",
  "invalidation_trigger": "A weekly close below $60 fills the late-April Q1 breakaway-gap shelf and retraces the entire post-Q1 re-rate. Secondary: a Q3 FY26 print with gross margin at or under the ~40% FY guide once the ~700bps tariff-refund benefit is out.",
  "catalyst_date": null,
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "consumer-discretionary-rotation"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Q2 FY26 gross margin of ~49% included roughly 700bps of one-time tariff refunds; management's own FY26 guide is ~40%, so reported margin is not a run rate.",
    "Copra, Inc. Acquisition closed 2026-07-22 for $175M cash; the $279M cash / no-debt balance sheet is dated at the Q2 close, before that outflow.",
    "Buyback authorization totals $105M after a $40M addition, with ~$44M repurchased through 2026-07-22 — the company is an active buyer of its own shares.",
    "Q3 FY26 earnings date was not announced as of 2026-08-07; any date circulating before company confirmation is an estimate.",
    "No listed coconut-water pure-play peer exists, so sympathy reads must be borrowed from the wider functional-beverage complex."
  ],
  "body_markdown": "## Current Thesis\nQ2 FY26, reported **2026-07-23**, delivered on the fundamental side without ambiguity — net sales **$216.2M, +28.1% YoY**, diluted EPS **$0.82** against roughly **$0.55** consensus, adjusted EBITDA **$67.2M (31% of net sales)** versus $29M (17%) a year earlier, and a full-year raise to **$790–805M net sales / $154–161M adjusted EBITDA**. The prior published condition for a fundamental break — a Q2 net sales figure below ~$185M — did not come close to triggering.\n\nThe price leg broke anyway. The 2026-07-12 trailing 52-week high was $79.70; StockStory marked it at $79.23 (May 2026) on 2026-07-23. The current basis carries a 52-week high of **$84.02** adjusted (**$85.83** unadjusted), which places the high in the days after the print — INFERRED from those two dated marks rather than observed directly. From there the stock closed **$62.25 on 2026-08-07**, **-25.9%** below that high, with RSI(14) at **27.5**. A beat-and-raise plus a $175M acquisition produced a marginal new high and then two weeks of supply.\n\nLife-cycle label: **SATURATED**, dated by the 2026-07-23 reaction. Mainstream coverage, an unambiguously good print, and a thin new bid on the other side of it. What is now being priced is not whether the category works but whether 2026 profitability is a run rate or a tariff-refund-flattered peak.\n\n## Bull Case\n- **Q2 FY26 (2026-07-23): net sales $216.2M, +28.1% YoY**, with growth in both branded and private-label coconut water. Volume- and mix-led.\n- **Diluted EPS $0.82 vs ~$0.55 consensus (~48% surprise); net income $49.5M vs $23.0M** in the year-ago quarter.\n- **FY26 guidance raised to $790–805M net sales and $154–161M adjusted EBITDA** (2026-07-23), against the late-April guide of $720–735M / $132–138M. Two dated guides, both raised inside one quarter.\n- **Balance sheet: $279M cash, no debt** at the Q2 close — a quarter-end date that precedes the Copra outflow.\n- **Buyback is live and expanded**: board added $40M to bring total authorization to **$105M**, with approximately **$44M already repurchased through 2026-07-22**. The company was a buyer while the stock was near its high.\n- **Copra, Inc. Acquired 2026-07-22 for $175M** — a super-premium Thai Nam Hom coconut water producer, adding both a price tier above the core brand and owned supply.\n- **Multiple has compressed while earnings rose**: trailing P/E **34.35** at the 2026-08-07 close, against the ~49x characterization carried into the July print.\n- **Published targets sit above spot**: Morgan Stanley $68 (2026-07-28), Piper Sandler $74 (2026-07-09), Wells Fargo $85 (2026-05-18) — all struck above the $62.25 close.\n\n## Bear Case\n- **The 49% Q2 gross margin is not the run rate.** Tariff refunds contributed roughly **700bps to Q2 gross margin** and ~300bps year-to-date, and management's own FY26 guide is **~40%**. The headline profitability that drove the July high carries a one-time component management has already guided away from.\n- **The catalyst came, the catalyst went.** The binary flagged in prior coverage landed on 2026-07-23, resolved bullish on every reported line, and the stock is **-25.9%** from its post-print high three weeks later. Good news absorbed at a new high is distribution behaviour.\n- **Morgan Stanley stayed Equal-Weight on 2026-07-28**, five days after the beat, lifting the target only to **$68**. The desk closest in time to the print did not upgrade.\n- **$175M of cash went out the door on 2026-07-22** against a $279M quarter-end balance struck before the close. Integration of a super-premium niche brand is unproven and nothing about its contribution has been quantified in a reported period.\n- **Private label was part of the growth mix.** Category expansion that runs through private label carries structurally lower margin than the branded line and dilutes the pricing-power story the multiple rests on.\n- **No dated catalyst inside the window.** As of 2026-08-07 the Q3 FY26 date had not been announced. A name that just failed from a high with nothing scheduled for roughly eleven weeks drifts on flow.\n- **Still a single name.** No coconut-water peer cluster confirms or contradicts the regime; sympathy reads have to be borrowed from the broader functional-beverage complex.\n\n## Setup & Price Structure\n- **Last close $62.25 (2026-08-07), -2.92% on the day.** Market cap **$3.65B**, trailing P/E **34.35**.\n- **52-week range $31.92–$85.83 unadjusted; $84.02 high on the adjusted basis.** Distance from high: **-25.9%**. Three-month return **-13.1%**.\n- **RSI(14) at 27.5** — below 30, so the decline is extended rather than crowded-long. Oversold on its own resolves nothing; it describes the speed of the move, not its endpoint.\n- Price sits **below** the mid-July estimated 50-day zone of ~$66–68 and well below the ~$72–74 20-EMA area estimated on 2026-07-12. Both moving-average references have rolled from support to overhead.\n- **The structural floor of the whole re-rate is the late-April Q1 breakaway gap, estimated near $60.** That shelf is what separates a violent give-back inside an uptrend from a full round-trip of the post-Q1 move. The 2026-08-07 close is roughly two dollars above it.\n- Positioning observables, stated as observables: buyback active into the drawdown ($44M through 2026-07-22, $105M authorized); no equity issuance into strength on the record; no earnings date scheduled; sell-side targets clustered $68–$85 with the nearest-dated one the lowest of the three.\n\n## Catalyst Calendar (next 30 days)\n\n- **~2026-10-29 (est.)** — Q3 FY26 print. Unconfirmed; this is the first scheduled event that can re-price the name, and it sits well outside the window.\n- **Ongoing, no fixed date** — repurchase activity under the $105M authorization. Disclosure arrives with the Q3 filing, not on a calendar date.\n\n## Elapsed catalysts\n\n- **Nothing dated falls inside the next 30 days.** As of 2026-08-07, the Q3 FY26 reporting date had not been announced by the company. *(passed 2d ago)*\n\n## What Would Change Our Mind\nThe structure that matters is the late-April Q1 breakaway gap near $60 — the only piece of the re-rate that has not already been surrendered. **A weekly close below $60** retraces the entire post-Q1 move and converts a sharp correction into a failed narrative; at that point the July beat-and-raise will have been fully sold and the burden shifts to the Q3 print to rebuild a base from below.\n\nOn the fundamental side, the specific datapoint that would confirm the bear reading is Q3 gross margin printing at or under the **~40%** full-year guide once the ~700bps tariff-refund benefit is absent, alongside any deceleration in branded Vita Coco Coconut Water relative to private label. Conversely, the case turns constructive again on a weekly reclaim of the mid-$70s with a higher low above $60 in between, or a Q3 print that holds gross margin above the FY guide on clean, non-refund mix. Absent either, the eleven-week gap to the next dated event is the whole problem: there is nothing scheduled that forces a re-rate in either direction, and the tape has been setting lower highs since the print.\n\n## Correlation Notes\n- **CELH remains the closest functional-beverage momentum analog** — same pattern of a high-multiple single-brand grower whose multiple travels with category-growth headlines rather than with staples beta.\n- **Input and freight sensitivity**: coconut/copra sourcing is concentrated in Southeast Asia, and the Q2 margin included tariff refunds. Trade-policy headlines on Thai and Philippine agricultural imports read directly into the gross-margin line, and the Copra deal (2026-07-22) increases that geographic concentration.\n- **No tight domestic peer set.** Coconut water has no listed pure-play comparison, so COCO trades as an idiosyncratic small/mid-cap growth name rather than as a member of a group; theme classification for this name has churned repeatedly and should be treated as low-information.\n- **Small-cap growth beta**: with $3.65B market cap and a 34x trailing multiple, drawdowns in high-multiple consumer growth tend to arrive on the same days regardless of company-specific news.",
  "first_seen": "2026-05-15",
  "last_analyzed": "2026-08-08T14:36:39+00:00",
  "last_synthesized": "2026-08-08",
  "last_update_source": "watchlist_research",
  "license": "Content © orbyd. Cite the canonical URL."
}